Moderna files 8-K: Director/Officer Change, Regulation FD Disclosure

Moderna filed a Form 8-K with the SEC on Sep 30, 2026, 7:15 AM ET, reporting an event dated Sep 30, 2026. It covers Item 5.02 (Departure or Election of Directors or Officers; Compensatory Arrangements); Item 7.01 (Regulation FD Disclosure); Item 9.01 (Financial Statements and Exhibits).

• Form 8-K accepted by EDGAR Sep 30, 2026, 7:15 AM ET
• Item 5.02 (Departure or Election of Directors or Officers; Compensatory Arrangements)
• Item 7.01 (Regulation FD Disclosure)
• Item 9.01 (Financial Statements and Exhibits)
• Accession number 0001193125-26-408289

SEC filing 8-K · accession 0001193125-26-408289 · sec.gov ↗